Total Payments
$61,416
2022 Payments
$24.03
Companies
9
Transactions
74
Medicare Patients
990
Medicare Billing
$195,809
Payment Breakdown by Category
Other$55,930 (91.1%)
Travel$2,621 (4.3%)
Consulting$1,533 (2.5%)
Food & Beverage$1,332 (2.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $55,930 | 17 | 91.1% |
| Travel and Lodging | $2,621 | 21 | 4.3% |
| Consulting Fee | $1,533 | 2 | 2.5% |
| Food and Beverage | $1,332 | 34 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $40,722 | 36 | $0 (2020) |
| GENZYME CORPORATION | $19,710 | 24 | $0 (2021) |
| Veran Medical Technologies, Inc. | $789.93 | 3 | $0 (2019) |
| Supernus Pharmaceuticals, Inc. | $103.25 | 6 | $0 (2019) |
| Pacira Pharmaceuticals Incorporated | $24.03 | 1 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $20.38 | 1 | $0 (2018) |
| Jazz Pharmaceuticals Inc. | $18.72 | 1 | $0 (2018) |
| Allergan, Inc. | $16.04 | 1 | $0 (2020) |
| The Medicines Company | $12.72 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $24.03 | 1 | Pacira Pharmaceuticals Incorporated ($24.03) |
| 2021 | $1,123 | 1 | GENZYME CORPORATION ($1,123) |
| 2020 | $9,753 | 11 | Regeneron Healthcare Solutions, Inc. ($6,277) |
| 2019 | $50,412 | 55 | Regeneron Healthcare Solutions, Inc. ($34,445) |
| 2018 | $91.24 | 5 | Supernus Pharmaceuticals, Inc. ($52.14) |
| 2017 | $12.72 | 1 | The Medicines Company ($12.72) |
All Payment Transactions
74 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/20/2022 | Pacira Pharmaceuticals Incorporated | Exparel (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: Pain Management | ||||||
| 06/01/2021 | GENZYME CORPORATION | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $1,123.00 | General |
| Category: Immunology | ||||||
| 08/20/2020 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $410.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/25/2020 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $71.30 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/19/2020 | Allergan, Inc. | STRATTICE (Device) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: TRAUMA EMERGENCY, INJURY, SURGERY | ||||||
| 02/13/2020 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,323.00 | General |
| Category: Immunology | ||||||
| 02/13/2020 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | Cash or cash equivalent | $87.40 | General |
| Category: Immunology | ||||||
| 02/13/2020 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $50.00 | General |
| Category: Immunology | ||||||
| 02/03/2020 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,322.50 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 01/30/2020 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 01/20/2020 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,325.75 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 01/20/2020 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $12.65 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 01/16/2020 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/30/2019 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $237.80 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/19/2019 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/11/2019 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,987.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/05/2019 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $89.94 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/22/2019 | GENZYME CORPORATION | DUPIXENT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,323.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2019 | GENZYME CORPORATION | DUPIXENT (Drug) | Travel and Lodging | Cash or cash equivalent | $116.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2019 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $38.28 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/12/2019 | GENZYME CORPORATION | DUPIXENT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,987.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2019 | GENZYME CORPORATION | DUPIXENT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,326.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2019 | GENZYME CORPORATION | DUPIXENT (Drug) | Travel and Lodging | Cash or cash equivalent | $184.44 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2019 | GENZYME CORPORATION | DUPIXENT (Drug) | Travel and Lodging | In-kind items and services | $119.80 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2019 | GENZYME CORPORATION | DUPIXENT (Drug) | Travel and Lodging | In-kind items and services | $105.80 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 284 | 436 | $139,534 | $50,731 |
| 2022 | 5 | 303 | 501 | $162,314 | $60,240 |
| 2021 | 7 | 248 | 409 | $145,750 | $56,490 |
| 2020 | 4 | 155 | 216 | $72,742 | $28,348 |
Total Patients
990
Total Services
1,562
Medicare Billing
$195,809
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 84 | 180 | $86,220 | $29,723 | 34.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 50 | 68 | $12,444 | $6,077 | 48.8% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 48 | 70 | $15,190 | $5,752 | 37.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 68 | 84 | $10,752 | $5,185 | 48.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 16 | 16 | $8,448 | $2,165 | 25.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 18 | 18 | $6,480 | $1,829 | 28.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 112 | 239 | $108,984 | $38,959 | 35.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 109 | 136 | $23,664 | $10,500 | 44.4% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 41 | 80 | $16,480 | $6,269 | 38.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 20 | 20 | $10,040 | $3,064 | 30.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 21 | 26 | $3,146 | $1,448 | 46.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 94 | 221 | $100,776 | $38,694 | 38.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 66 | 96 | $16,704 | $7,868 | 47.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 29 | 29 | $14,558 | $4,450 | 30.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 15 | 15 | $5,130 | $1,621 | 31.6% |
| 31500 | Emergent insertion of breathing tube into windpipe cartilage using an endoscope | Facility | 2021 | 12 | 12 | $3,036 | $1,399 | 46.1% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2021 | 14 | 14 | $2,884 | $1,240 | 43.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 18 | 22 | $2,662 | $1,217 | 45.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 56 | 102 | $46,265 | $18,251 | 39.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 46 | 47 | $15,784 | $5,016 | 31.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 37 | 48 | $8,430 | $3,971 | 47.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 16 | 19 | $2,263 | $1,110 | 49.1% |
About Dr. Daniel Pearson, M.D
Dr. Daniel Pearson, M.D is a Internal Medicine healthcare provider based in Dayton, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/31/2011. The National Provider Identifier (NPI) number assigned to this provider is 1962708552.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Pearson, M.D has received a total of $61,416 in payments from pharmaceutical and medical device companies, with $24.03 received in 2022. These payments were reported across 74 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($55,930).
As a Medicare-enrolled provider, Pearson has provided services to 990 Medicare beneficiaries, totaling 1,562 services with total Medicare billing of $195,809. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Critical Care Medicine, Critical Care Medicine
- Location Dayton, OH
- Active Since 01/31/2011
- Last Updated 03/27/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1962708552
Products in Payments
- DUPIXENT (Biological) $45,305
- DUPIXENT (Drug) $15,126
- Spin (Device) $789.93
- TROKENDI XR (Drug) $103.25
- Exparel (Drug) $24.03
- APTIOM (Drug) $20.38
- Xyrem (Drug) $18.72
- STRATTICE (Device) $16.04
- MINOCIN IV (Drug) $12.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Dayton
Miguel Parilo, Md, MD
Internal Medicine — Payments: $165,368
Internal Medicine $165,368
Dr. Isaac Humphrey, M.d, M.D
Internal Medicine — Payments: $150,806
Internal Medicine $150,806
Kirshan Lal, Md, MD
Internal Medicine — Payments: $82,779
Internal Medicine $82,779
Dr. Mohamed Elmouelhi, Md, Phd, MD, PHD
Internal Medicine — Payments: $44,032
Internal Medicine $44,032
Mamle Anim, Md, MD
Internal Medicine — Payments: $35,552
Internal Medicine $35,552
Dr. Glenda Lopez-Blaza, M.d, M.D
Internal Medicine — Payments: $33,145
Internal Medicine $33,145